Crystagen (20mg Vial)

01 · At a glance

Quickstart Highlights

Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration. Typical daily range: 1000–2000 mcg once daily (gradual titration to 2000 mcg). Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe. Storage: Lyophilized: refrigerate at 4 °C (39.2 °F) or freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 4 °C (39.2 °F) for up to 30 days.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = 6.67 mg/mL)

1000–2000 mcg once daily (gradual titration to 2000 mcg).

Reconstitution Steps

1. Confirm the vial amount, unit, and diluent amount before entering values in the calculator.
2. Add diluent slowly down the inner wall of the vial when reconstitution is appropriate for the compound.
3. Swirl or roll gently until dissolved; avoid shaking unless the product instructions specifically say otherwise.
4. Label the vial with the date and concentration, then store according to the protocol and product instructions.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Support immune system modulation and cellular regulation through bioregulatory peptide signaling [1] [2] .
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 1000–2000 mcg daily with gradual titration over 2 weeks.
• Reconstitution: 3.0 mL per 20 mg vial (6.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized: refrigerate or freeze; reconstituted: refrigerate for up to 30 days [5] [6]

Dosing Protocol

• Suggested daily titration approach.
• Week 1: 1000 mcg (1 mg) daily to assess tolerance.
• Week 2: 1500 mcg (1.5 mg) daily.
• Weeks 3–12: 2000 mcg (2 mg) daily (target maintenance dose).
• Frequency: Once per day (subcutaneous), consistent timing recommended.
• Cycle Length: 8–12 weeks standard; optional extension to 16 weeks for research observation.
• Timing: Any consistent time daily; rotate injection sites to prevent irritation.

Storage Instructions

• Lyophilized: refrigerate at 4 °C (39.2 °F) or freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 4 °C (39.2 °F) for up to 30 days.
• Storage: Lyophilized: refrigerate or freeze; reconstituted: refrigerate for up to 30 days [5] [6]
• Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

• Practical considerations for consistency and safety.
• Use new sterile insulin syringes for each injection; dispose in a sharps container [10] .
• Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy [8] .
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose, injection site, and any observations to maintain protocol consistency.
• Follow aseptic technique: wash hands thoroughly and cleanse skin with alcohol before each injection.

05 · How it works

How This Works

Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration.

Typical daily range: 1000–2000 mcg once daily (gradual titration to 2000 mcg).

Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• Crystagen observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
• This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

09 · Evidence

References